Infosys reported revenue at $ 4718 million, up 2.3% q-o-q / 2.5% y-o-y in cc exceeding our estimates of 0.7% q-o-q CC revenue growth in a seasonally strong quarter led by growth across Lifesciences, Manufacturing and Retail vertical. EBIT margin improved ~40 bps q-o-q to 21.2 %, beating our estimates of 20.7% aided by benefits of its margin improvement plan. Company reported highest ever large deal TCV wins at $7.7 billion with net new deal TCV at 48%. Management has cut the FY24 CC revenue guidance to 1-2.5% from 1-3.5%. However, the management has retained EBIT margin guidance for the financial year at 20-22%. We believe the large deal signing and strong pipeline are setting the tone for growth and acceleration beyond FY24 and we see Infosys as a beneficiary of a recovery in discretionary spends and vendor consolidation, given its strong execution track record and capabilities.
OutlookHence, we maintain a Buy on Infosys with an unchanged PT of Rs. 1,690. At the CMP, the stock trades at 21.1x/18.4x its FY25/26E EPS.
For all recommendations report, click hereDisclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
Infosys - 13 - 10-2023 - khanDiscover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.
